The Hindu Business Line : Bal Pharma turnover up 18 pc

BANGALORE: Bal Pharma Ltd has posted a gross turnover of Rs 18.44 crore for the quarter ended September 30 this year, registering nearly an 18-per cent growth over Rs 15.63 crore for the same quarter last year. Profit after tax was Rs 1.04 crore (Rs 0.74 crore).

The basic EPS for the BSE-listed pharma company was 1.08 (1.55).

For the half-year ended September 30, Bal Pharma gross turnover was up 13.39 per cent at Rs 36.32 crore. Profit after tax went up 41.9 per cent to Rs 2.2 crore (Rs 1.55 crore). The six-month profit is more than the entire previous year's profit. The PBT of Rs 2.85 crore was 43 per cent higher than the 2004-05 PBT of Rs 19.92 crore for the same period.

Mr Shailesh D. Siroya, MD, said, "The growth is in line with the company's focus to promote branded products and bulk drugs in the domestic and world markets. The changed strategy has worked in favour of the organisation and our expectation of entering the regulated market looks very promising."

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Aurobindo Pharma Q2 net up 42.18 pc

Bal Pharma turnover up 18 pc

Bannari Amman Sugars net up 61 pc

SQL Star posts profit

Lakshmi Machine Works Q2 net up 77 pc at Rs 19.91 cr